annual EBIT:
$583.00M+$246.30M(+73.15%)Summary
- As of today (May 29, 2025), NBIX annual earnings before interest & taxes is $583.00 million, with the most recent change of +$246.30 million (+73.15%) on December 31, 2024.
- During the last 3 years, NBIX annual EBIT has risen by +$455.80 million (+358.33%).
- NBIX annual EBIT is now at all-time high.
Performance
NBIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$23.70M-$150.90M(-86.43%)Summary
- As of today (May 29, 2025), NBIX quarterly earnings before interest & taxes is $23.70 million, with the most recent change of -$150.90 million (-86.43%) on March 31, 2025.
- Over the past year, NBIX quarterly EBIT has dropped by -$81.60 million (-77.49%).
- NBIX quarterly EBIT is now -87.18% below its all-time high of $184.80 million, reached on September 30, 2024.
Performance
NBIX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$531.00M-$81.60M(-13.32%)Summary
- As of today (May 29, 2025), NBIX TTM earnings before interest & taxes is $531.00 million, with the most recent change of -$81.60 million (-13.32%) on March 31, 2025.
- Over the past year, NBIX TTM EBIT has increased by +$60.60 million (+12.88%).
- NBIX TTM EBIT is now -13.32% below its all-time high of $612.60 million, reached on December 31, 2024.
Performance
NBIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NBIX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.2% | -77.5% | +12.9% |
| 3 y3 years | +358.3% | -1.3% | +351.5% |
| 5 y5 years | +642.7% | -49.7% | +141.0% |
NBIX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +358.3% | -87.2% | +123.2% | -13.3% | +1518.9% |
| 5 y | 5-year | at high | +642.7% | -87.2% | +123.2% | -13.3% | +1518.9% |
| alltime | all time | at high | +374.7% | -87.2% | +118.4% | -13.3% | +346.9% |
NBIX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $23.70M(-86.4%) | $531.00M(-13.3%) |
| Dec 2024 | $583.00M(+73.2%) | $174.60M(-5.5%) | $612.60M(+4.1%) |
| Sep 2024 | - | $184.80M(+24.9%) | $588.30M(+8.0%) |
| Jun 2024 | - | $147.90M(+40.5%) | $544.70M(+15.8%) |
| Mar 2024 | - | $105.30M(-29.9%) | $470.40M(+78.9%) |
| Dec 2023 | $336.70M(+52.4%) | $150.30M(+6.4%) | $262.90M(+1.3%) |
| Sep 2023 | - | $141.20M(+91.8%) | $259.60M(+19.4%) |
| Jun 2023 | - | $73.60M(-172.0%) | $217.50M(+77.1%) |
| Mar 2023 | - | -$102.20M(-169.5%) | $122.80M(-50.7%) |
| Dec 2022 | $221.00M(+73.7%) | $147.00M(+48.3%) | $249.00M(+162.7%) |
| Sep 2022 | - | $99.10M(-569.7%) | $94.80M(+189.0%) |
| Jun 2022 | - | -$21.10M(-187.9%) | $32.80M(-72.1%) |
| Mar 2022 | - | $24.00M(-433.3%) | $117.60M(-7.5%) |
| Dec 2021 | $127.20M(-8.8%) | -$7.20M(-119.4%) | $127.20M(-30.8%) |
| Sep 2021 | - | $37.10M(-41.8%) | $183.90M(+87.3%) |
| Jun 2021 | - | $63.70M(+89.6%) | $98.20M(-22.1%) |
| Mar 2021 | - | $33.60M(-32.1%) | $126.00M(-9.7%) |
| Dec 2020 | $139.50M(+77.7%) | $49.50M(-201.9%) | $139.50M(+2.0%) |
| Sep 2020 | - | -$48.60M(-153.1%) | $136.80M(-45.7%) |
| Jun 2020 | - | $91.50M(+94.3%) | $251.80M(+14.3%) |
| Mar 2020 | - | $47.10M(+0.6%) | $220.30M(+180.6%) |
| Dec 2019 | $78.50M(+50.1%) | $46.80M(-29.5%) | $78.50M(+34.9%) |
| Sep 2019 | - | $66.40M(+10.7%) | $58.20M(+15.9%) |
| Jun 2019 | - | $60.00M(-163.4%) | $50.24M(-721.3%) |
| Mar 2019 | - | -$94.70M(-457.4%) | -$8.09M(-115.5%) |
| Dec 2018 | $52.30M(-142.5%) | $26.50M(-54.7%) | $52.30M(+30.4%) |
| Sep 2018 | - | $58.44M(+3382.5%) | $40.11M(-281.4%) |
| Jun 2018 | - | $1.68M(-104.9%) | -$22.11M(-72.0%) |
| Mar 2018 | - | -$34.31M(-339.7%) | -$79.01M(-35.8%) |
| Dec 2017 | -$123.02M(-12.8%) | $14.31M(-477.9%) | -$123.02M(-32.4%) |
| Sep 2017 | - | -$3.79M(-93.1%) | -$181.99M(-15.4%) |
| Jun 2017 | - | -$55.22M(-29.5%) | -$215.09M(+7.5%) |
| Mar 2017 | - | -$78.33M(+75.4%) | -$200.15M(+40.3%) |
| Dec 2016 | -$141.09M(+58.7%) | -$44.66M(+21.1%) | -$142.68M(+15.5%) |
| Sep 2016 | - | -$36.89M(-8.4%) | -$123.50M(+0.9%) |
| Jun 2016 | - | -$40.28M(+93.1%) | -$122.46M(+13.9%) |
| Mar 2016 | - | -$20.86M(-18.1%) | -$107.50M(+20.9%) |
| Dec 2015 | -$88.93M(+38.1%) | -$25.48M(-28.9%) | -$88.93M(+6.0%) |
| Sep 2015 | - | -$35.84M(+41.6%) | -$83.92M(+29.2%) |
| Jun 2015 | - | -$25.32M(+1006.7%) | -$64.94M(+20.3%) |
| Mar 2015 | - | -$2.29M(-88.8%) | -$53.97M(-16.2%) |
| Dec 2014 | -$64.41M(+29.7%) | -$20.47M(+21.4%) | -$64.41M(+16.1%) |
| Sep 2014 | - | -$16.86M(+17.4%) | -$55.47M(+9.6%) |
| Jun 2014 | - | -$14.36M(+12.9%) | -$50.62M(+2.4%) |
| Mar 2014 | - | -$12.72M(+10.4%) | -$49.43M(-0.5%) |
| Dec 2013 | -$49.68M(-3530.8%) | -$11.53M(-4.0%) | -$49.68M(+68.0%) |
| Sep 2013 | - | -$12.01M(-8.8%) | -$29.57M(+37.4%) |
| Jun 2013 | - | -$13.17M(+1.5%) | -$21.52M(+121.1%) |
| Mar 2013 | - | -$12.97M(-251.2%) | -$9.73M(-772.3%) |
| Dec 2012 | $1.45M(-95.7%) | $8.58M(-316.6%) | $1.45M(-121.7%) |
| Sep 2012 | - | -$3.96M(+187.1%) | -$6.69M(-124.1%) |
| Jun 2012 | - | -$1.38M(-23.0%) | $27.71M(-8.2%) |
| Mar 2012 | - | -$1.79M(-500.9%) | $30.19M(-11.0%) |
| Dec 2011 | $33.92M(-347.2%) | $447.00K(-98.5%) | $33.92M(+1.7%) |
| Sep 2011 | - | $30.44M(+2677.4%) | $33.35M(+520.7%) |
| Jun 2011 | - | $1.10M(-43.5%) | $5.37M(-432.8%) |
| Mar 2011 | - | $1.94M(-1603.1%) | -$1.61M(-88.2%) |
| Dec 2010 | -$13.72M | -$129.00K(-105.2%) | -$13.72M(-47.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $2.47M(-141.9%) | -$25.87M(-31.9%) |
| Jun 2010 | - | -$5.89M(-42.1%) | -$37.97M(-19.2%) |
| Mar 2010 | - | -$10.17M(-17.2%) | -$46.99M(-8.1%) |
| Dec 2009 | -$51.11M(-37.4%) | -$12.28M(+27.5%) | -$51.11M(-19.9%) |
| Sep 2009 | - | -$9.63M(-35.4%) | -$63.84M(-8.7%) |
| Jun 2009 | - | -$14.90M(+4.2%) | -$69.91M(-6.9%) |
| Mar 2009 | - | -$14.30M(-42.8%) | -$75.12M(-7.9%) |
| Dec 2008 | -$81.59M(-61.6%) | -$25.00M(+59.2%) | -$81.59M(-55.9%) |
| Sep 2008 | - | -$15.70M(-21.9%) | -$185.18M(-6.6%) |
| Jun 2008 | - | -$20.12M(-3.1%) | -$198.30M(-3.6%) |
| Mar 2008 | - | -$20.76M(-83.9%) | -$205.73M(-3.1%) |
| Dec 2007 | -$212.24M(+87.3%) | -$128.59M(+346.1%) | -$212.24M(+112.4%) |
| Sep 2007 | - | -$28.83M(+4.6%) | -$99.91M(-10.2%) |
| Jun 2007 | - | -$27.55M(+1.0%) | -$111.28M(-1.5%) |
| Mar 2007 | - | -$27.27M(+67.7%) | -$113.00M(-0.3%) |
| Dec 2006 | -$113.32M(+352.0%) | -$16.26M(-59.5%) | -$113.32M(-6.8%) |
| Sep 2006 | - | -$40.20M(+37.4%) | -$121.65M(+116.0%) |
| Jun 2006 | - | -$29.26M(+6.1%) | -$56.33M(+69.1%) |
| Mar 2006 | - | -$27.59M(+12.2%) | -$33.32M(+32.9%) |
| Dec 2005 | -$25.07M(-52.1%) | -$24.59M(-197.9%) | -$25.07M(+15.7%) |
| Sep 2005 | - | $25.12M(-501.8%) | -$21.66M(-56.5%) |
| Jun 2005 | - | -$6.25M(-67.7%) | -$49.81M(-12.5%) |
| Mar 2005 | - | -$19.35M(-8.7%) | -$56.95M(+8.8%) |
| Dec 2004 | -$52.33M(-11.0%) | -$21.18M(+598.9%) | -$52.33M(+7.9%) |
| Sep 2004 | - | -$3.03M(-77.4%) | -$48.52M(-17.9%) |
| Jun 2004 | - | -$13.39M(-9.1%) | -$59.06M(+1.5%) |
| Mar 2004 | - | -$14.73M(-15.2%) | -$58.16M(-1.1%) |
| Dec 2003 | -$58.79M(-43.3%) | -$17.37M(+28.0%) | -$58.79M(-28.9%) |
| Sep 2003 | - | -$13.57M(+8.7%) | -$82.69M(-9.7%) |
| Jun 2003 | - | -$12.49M(-18.6%) | -$91.62M(-9.4%) |
| Mar 2003 | - | -$15.35M(-62.8%) | -$101.15M(-2.4%) |
| Dec 2002 | -$103.61M(+136.1%) | -$41.27M(+83.4%) | -$103.61M(+33.3%) |
| Sep 2002 | - | -$22.50M(+2.2%) | -$77.75M(+43.8%) |
| Jun 2002 | - | -$22.02M(+23.6%) | -$54.05M(+13.5%) |
| Mar 2002 | - | -$17.82M(+15.7%) | -$47.62M(+8.5%) |
| Dec 2001 | -$43.88M(+23.3%) | -$15.40M(-1391.2%) | -$43.88M(+10.3%) |
| Sep 2001 | - | $1.19M(-107.7%) | -$39.79M(-21.5%) |
| Jun 2001 | - | -$15.59M(+10.7%) | -$50.67M(+19.3%) |
| Mar 2001 | - | -$14.08M(+24.5%) | -$42.45M(+19.2%) |
| Dec 2000 | -$35.60M(+78.9%) | -$11.31M(+16.8%) | -$35.60M(+21.5%) |
| Sep 2000 | - | -$9.69M(+31.2%) | -$29.29M(+19.0%) |
| Jun 2000 | - | -$7.38M(+2.1%) | -$24.61M(+9.3%) |
| Mar 2000 | - | -$7.23M(+44.5%) | -$22.52M(+13.8%) |
| Dec 1999 | -$19.90M(+60.5%) | -$5.00M(0.0%) | -$19.79M(+7.0%) |
| Sep 1999 | - | -$5.00M(-5.5%) | -$18.49M(+11.5%) |
| Jun 1999 | - | -$5.29M(+17.6%) | -$16.59M(+12.9%) |
| Mar 1999 | - | -$4.50M(+21.6%) | -$14.70M(+16.7%) |
| Dec 1998 | -$12.40M(-2580.0%) | -$3.70M(+19.4%) | -$12.60M(+23.5%) |
| Sep 1998 | - | -$3.10M(-8.8%) | -$10.20M(+36.0%) |
| Jun 1998 | - | -$3.40M(+41.7%) | -$7.50M(+50.0%) |
| Mar 1998 | - | -$2.40M(+84.6%) | -$5.00M(-933.3%) |
| Dec 1997 | $500.00K(-82.8%) | -$1.30M(+225.0%) | $600.00K(-88.5%) |
| Sep 1997 | - | -$400.00K(-55.6%) | $5.20M(+26.8%) |
| Jun 1997 | - | -$900.00K(-128.1%) | $4.10M(-34.9%) |
| Mar 1997 | - | $3.20M(-3.0%) | $6.30M(+117.2%) |
| Dec 1996 | $2.90M | $3.30M(-320.0%) | $2.90M(-825.0%) |
| Sep 1996 | - | -$1.50M(-215.4%) | -$400.00K(-136.4%) |
| Jun 1996 | - | $1.30M(-750.0%) | $1.10M(-650.0%) |
| Mar 1996 | - | -$200.00K | -$200.00K |
FAQ
- What is Neurocrine Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual EBIT year-on-year change?
- What is Neurocrine Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly EBIT year-on-year change?
- What is Neurocrine Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM EBIT year-on-year change?
What is Neurocrine Biosciences annual earnings before interest & taxes?
The current annual EBIT of NBIX is $583.00M
What is the all time high annual EBIT for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual earnings before interest & taxes is $583.00M
What is Neurocrine Biosciences annual EBIT year-on-year change?
Over the past year, NBIX annual earnings before interest & taxes has changed by +$246.30M (+73.15%)
What is Neurocrine Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of NBIX is $23.70M
What is the all time high quarterly EBIT for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly earnings before interest & taxes is $184.80M
What is Neurocrine Biosciences quarterly EBIT year-on-year change?
Over the past year, NBIX quarterly earnings before interest & taxes has changed by -$81.60M (-77.49%)
What is Neurocrine Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of NBIX is $531.00M
What is the all time high TTM EBIT for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM earnings before interest & taxes is $612.60M
What is Neurocrine Biosciences TTM EBIT year-on-year change?
Over the past year, NBIX TTM earnings before interest & taxes has changed by +$60.60M (+12.88%)